ARCT
NASDAQStockArcturus Therapeutics Holdings Inc.
$6.67-0.33 (-4.71%)
52-Week Range
$5.90
$23.16
Key Stats
Market Cap
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.49
Volume
284.4K
Avg Volume
501.9K
Performance
1M
-5.41%
3M
-3.45%
6M
-61.39%
YTD
+12.00%
1Y
-49.64%
3Y
-55.70%
5Y
-86.59%
Price Chart
ETF Exposure
ARCT is held by 53 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MSGR | Direxion mRNA ETF | 7.45% |
| TYNE | Direxion Nanotechnology ETF | 5.24% |
| JFWD | Jacob Forward ETF | 2.21% |
| ARKG | ARK Genomic Revolution ETF | 1.76% |
| GERM | ETFMG Treatments, Testing and Advancements ETF | 1.15% |
| WDNA | WisdomTree BioRevolution Fund | 0.80% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.23% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.14% |
| STSB | iShares Factors US Small Blend Style ETF | 0.07% |
| IWC | iShares Micro-Cap ETF | 0.04% |
| NUSC | Nuveen ESG Small-Cap | 0.04% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.03% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.02% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.02% |
| IBB | iShares Biotechnology ETF | 0.02% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.02% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.01% |
| IWN | iShares Russell 2000 Value ETF | 0.01% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.01% |
| VALT | ETFMG Sit Ultra Short ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.01% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.00% |
| URTY | ProShares - UltraPro Russell2000 | 0.00% |
| UWM | ProShares - Ultra Russell2000 | 0.00% |
| VHT | Vanguard Health Care ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
Page 1 of 2Next
About ARCT ETF Exposure
Arcturus Therapeutics Holdings Inc. (ARCT) is held by 53 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $6.67. Investors can gain exposure to ARCT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ARCT, sorted by portfolio weight.